We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN®

News   Aug 14, 2008

 
U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN®
 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Rare and Undiagnosed Conditions Get Massive Research Funding Boost

News

Five new clinical sites, a new metabolomics core, and increased model organism capabilities among additions.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE